Treatment With AZD4547 for Recurrent Malignant Glioma Expressing FGFR-TACC Gene Fusion"

Clinical trial NCT02824133 · COMPLETED

Trial details

NCT number: NCT02824133
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent IDHwt Gliomas With FGFR3-TACC3 Fusion Recurrent IDHwt Gliomas With FGFR1-TACC1 Fusion

Start date: 2015-09-01
Primary completion: 2017-09-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.